Development Description
Permission for development at Eli Lilly Kinsale pharmaceutical manufacturing campus. The proposed development will consist of: (1) Construction of a 3 storey laboratory extension to the existing laboratory/administration building (known as IE28) to comprise gross floor area of approximately 4,277sqm with height to parapet of approximately 19.62m and maximum height (roof top mechanical unit lourve) of 24.25m. (2) Re-alignment of the existing internal security fence and provision of pedestrian turnstile access. (3) All associated site development works including modification to adjacent internal site roads and site services, drainage connections, provision of hard standing areas and landscaping. The proposed development is located on a site that operates under an existing Industrial Emissions (IE) Licence (no. P0009-05) under Part IV of the Environmental Protection Agency Act 1992 (as amended for the Protection of the Environmental Act, 2003). The proposed development is on a site which the Chemicals Act (Control of Major Accident Hazards involving Dangerous Substances) Regulations 2015 (S.I 209 of 2015) applies.
Map
No coordinates supplied in the public planning feed.